• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个大型拉丁美洲患者队列中,多发性硬化症护理服务获取和利用的障碍。

Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patients.

机构信息

Neuroimmunology Unit, Department of Neuroscience, Hospital Alemán, Buenos Aires, Argentina.

Asociación de Lucha Contra la Esclerosis Múltiple (ALCEM), Buenos Aires, Argentina.

出版信息

Mult Scler. 2021 Jan;27(1):117-129. doi: 10.1177/1352458519898590. Epub 2020 Jan 21.

DOI:10.1177/1352458519898590
PMID:31961260
Abstract

BACKGROUND

Multiple sclerosis (MS), is an emergent disease in Latin America (LATAM), which raises substantial socioeconomic challenges to a region where most countries remain as economies in development.

OBJECTIVE

To assess barriers to access and utilization of MS care services in a regional cohort survey.

METHODS

We conducted a cross-sectional study based on a self-reported survey. Patients with MS (PwMS) completed this regional survey in 12 Latin American (LATAM) countries. PwMS were also divided into those with healthcare insurance (including certain local national social security programs) and those without healthcare insurance (treated at public institutions).

RESULTS

We surveyed 1469 PwMS and identified significant regional differences in relation to access to complementary tests, rehabilitation services, and prescription of disease-modifying therapies (DMTs). Between 44.4% and 73.5% of PwMS were unemployed and nearly 50% had completed higher education. PwMS receiving care from the private sector reported greater access to imaging, DMTs, and fewer problems obtaining DMTs compared to those treated at public institutions. Multivariate analysis showed that lack of private insurance (OR = 2.21,  < 0.001), longer MS duration (OR = 1.02,  = 0.001), lower level of education (OR = 0.66,  = 0.009), and unemployment (OR = 0.73,  = 0.03) were independently associated with inappropriate delivery of DMTs.

CONCLUSION

These findings suggest barriers to access and utilization of MS care services across LATAM are prevalent. We identified several factors predicting unmet healthcare needs in PwMS.

摘要

背景

多发性硬化症(MS)在拉丁美洲(LATAM)是一种新兴疾病,这给该地区带来了巨大的社会经济挑战,因为该地区大多数国家仍处于发展中经济体的地位。

目的

在区域队列调查中评估 MS 护理服务的获取和利用障碍。

方法

我们进行了一项基于自我报告调查的横断面研究。MS 患者(PwMS)在 12 个拉丁美洲(LATAM)国家完成了这项区域调查。PwMS 还分为有医疗保险(包括某些当地国家的社会保障计划)和没有医疗保险(在公共机构接受治疗)。

结果

我们调查了 1469 名 PwMS,并发现与获得补充检查、康复服务和处方疾病修正疗法(DMT)相关的显著区域差异。44.4%至 73.5%的 PwMS 失业,近 50%的人完成了高等教育。与在公共机构接受治疗的患者相比,从私营部门接受治疗的 PwMS 报告称更容易获得影像学检查、DMT,并且在获得 DMT 方面遇到的问题更少。多变量分析表明,缺乏私人保险(OR=2.21,<0.001)、MS 病程较长(OR=1.02,=0.001)、教育水平较低(OR=0.66,=0.009)和失业(OR=0.73,=0.03)与不适当的 DMT 治疗独立相关。

结论

这些发现表明,LATAM 普遍存在获取和利用 MS 护理服务的障碍。我们确定了一些预测 PwMS 未满足医疗需求的因素。

相似文献

1
Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patients.在一个大型拉丁美洲患者队列中,多发性硬化症护理服务获取和利用的障碍。
Mult Scler. 2021 Jan;27(1):117-129. doi: 10.1177/1352458519898590. Epub 2020 Jan 21.
2
Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.2019冠状病毒病大流行对多发性硬化症患者护理及预后的间接影响:一项综合调查与保险理赔研究
Mult Scler Relat Disord. 2023 Dec;80:105085. doi: 10.1016/j.msard.2023.105085. Epub 2023 Oct 16.
3
Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic.拉丁美洲多发性硬化症患者在 COVID-19 大流行期间的医疗保健变化。
Mult Scler Relat Disord. 2021 Sep;54:103120. doi: 10.1016/j.msard.2021.103120. Epub 2021 Jun 30.
4
Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patients.阿根廷患者队列中多发性硬化症护理的可及性和未满足需求。
Mult Scler Relat Disord. 2019 Aug;33:88-93. doi: 10.1016/j.msard.2019.05.024. Epub 2019 May 30.
5
Access and barriers to MS care in Latin America.拉丁美洲多发性硬化症护理的获取情况与障碍
Mult Scler J Exp Transl Clin. 2017 Mar 23;3(1):2055217317700668. doi: 10.1177/2055217317700668. eCollection 2017 Jan-Mar.
6
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.多发性硬化症未满足的需求、治疗负担和患者参与:21 世纪多发性硬化症指导小组的综合观点。
Mult Scler Relat Disord. 2018 Jan;19:153-160. doi: 10.1016/j.msard.2017.11.013. Epub 2017 Nov 21.
7
Descriptive analysis of free-text comments on healthcare priorities and experiences in a national sample of people with multiple sclerosis.对全国多发性硬化症患者样本中关于医疗保健重点和体验的自由文本评论进行描述性分析。
Mult Scler Relat Disord. 2019 Sep;34:141-149. doi: 10.1016/j.msard.2019.06.023. Epub 2019 Jun 22.
8
Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America.评估拉丁美洲多发性硬化症患者的治疗依从性。
Mult Scler Relat Disord. 2022 Jul;63:103915. doi: 10.1016/j.msard.2022.103915. Epub 2022 Jun 1.
9
Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement.多主体系统动力学在东南亚获得多发性硬化症疾病修正治疗中的应用:区域调查及改进建议。
Mult Scler Relat Disord. 2024 May;85:105555. doi: 10.1016/j.msard.2024.105555. Epub 2024 Mar 18.
10
The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study.疾病改善治疗获取障碍对多发性硬化症患者的影响:混合方法研究
J Med Internet Res. 2018 Oct 30;20(10):e11168. doi: 10.2196/11168.

引用本文的文献

1
Multiple Sclerosis Care in Latin America.拉丁美洲的多发性硬化症护理
Int J MS Care. 2024 Dec 1;27(Theme):T7-T12. doi: 10.7224/1537-2073.2024-085. eCollection 2024 Dec.
2
The impact of educational attainment on diagnostic and treatment delays in multiple sclerosis: a nationwide cohort study in Denmark.教育程度对多发性硬化症诊断和治疗延迟的影响:丹麦的一项全国性队列研究。
Ther Adv Neurol Disord. 2025 Feb 14;18:17562864251313918. doi: 10.1177/17562864251313918. eCollection 2025.
3
Barriers to clinical follow-up visits in multiple sclerosis: A nationwide register-based study.
多发性硬化症临床随访的障碍:一项基于全国登记系统的研究。
Mult Scler J Exp Transl Clin. 2024 Dec 18;10(4):20552173241307619. doi: 10.1177/20552173241307619. eCollection 2024 Oct-Dec.
4
Access to health insurance amongst people with disabilities and its association with healthcare use, health status and financial protection in low- and middle-income countries: a systematic review.低收入和中等收入国家残疾人的医疗保险覆盖情况及其与医疗服务利用、健康状况和经济保护的关联:一项系统综述
Int J Equity Health. 2024 Dec 18;23(1):264. doi: 10.1186/s12939-024-02339-5.
5
[Core data set for real world data in multiple sclerosis: customization for latin america from a global task force recommendation].[多发性硬化症真实世界数据的核心数据集:根据全球特别工作组的建议为拉丁美洲进行定制]
Rev Neurol. 2024 Apr 1;78(7):185-197. doi: 10.33588/rn.7807.2023326.
6
Editorial: Real-world study of multiple sclerosis and related diseases in developing countries.社论:发展中国家多发性硬化症及相关疾病的真实世界研究
Front Neurol. 2023 Nov 30;14:1336598. doi: 10.3389/fneur.2023.1336598. eCollection 2023.
7
A review of neurological health disparities in Peru.秘鲁神经健康差异研究综述。
Front Public Health. 2023 Sep 7;11:1210238. doi: 10.3389/fpubh.2023.1210238. eCollection 2023.
8
Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.使用 EQ-5D-5L、AQoL-8D、EQ-5D-5L-psychosocial 和 SF-6D 评估复发缓解型和继发进展型多发性硬化的复发失能程度:对健康经济评价模型的影响。
Qual Life Res. 2023 Dec;32(12):3373-3387. doi: 10.1007/s11136-023-03486-y. Epub 2023 Jul 31.
9
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.在用克拉屈滨和单克隆抗体治疗的高度活动性多发性硬化症患者中实现疾病活动-3无证据状态
Mult Scler J Exp Transl Clin. 2023 Feb 22;9(1):20552173231154712. doi: 10.1177/20552173231154712. eCollection 2023 Jan-Mar.
10
The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis.社会经济地位对多发性硬化症后续神经学结局的影响。
Mult Scler Relat Disord. 2022 Sep;65:103994. doi: 10.1016/j.msard.2022.103994. Epub 2022 Jun 24.